The team of Miikka Vikkula  and colleagues discovered a genetic cause for CCLA, a serious and rare disease affecting the central lymphatic vessel system.

Benoît Vanholleke and his team demonstrated that modulating Gpr124/ could restore the permeability of cerebral blood vessels in models of brain pathologies.  

Guido Bommer and his team identified a new role for PARK7  an enzyme that is inactive in some Parkinson's disease patients.

David Alsteens and his team demonstrated the role of α-sialylated glycans in enhancing oncolytic therapy in breast cancer using atomic force microscopy.

Cédric Blanpain is the 2022 winner of the EACR’s Mike Price Gold Medal, which rewards a senior researcher who has made an outstanding contribution to the progress of cancer research in Europe.

Alain Chariot and his team demonstrated that COP1 can act as an oncogenic E3 ligase by promoting ERa signaling but also as a tumor suppressor candidate by preventing epithelial-mesenchymal transition.

From fundamental research on bacterial metabolism in Abel Garcia-Pino's laboratory to the development of a new generation of antibiotics.

The Ernest Solvay 2020 Prize of the Queen Elisabeth Medical Foundation was awarded to Benoît Vanhollebeke at a ceremony attended by Her Majesty the Queen.

The FRFS-WELBIO announces its 2021 call for "WELBIO Investigator programmes" for basic research in the fields of life sciences that can lead to applications in all fields of (bio)technology.

Le Prix Joseph Maisin en Sciences biomédicales fondamentales 2020 a été attribué à Jean-François Collet lors d’une cérémonie en présence de Sa Majesté le Roi.

Abel Garcia-Pino and his team shed light on the role played by  alarmone for induction of the synthetic activity of E. coli RelA by starved ribosomes.

Abel Garcia-Pino and his team uncovered the mechanism of toxicity used by the toxin-antitoxin systems (toxSAS) in bacteria.